Work

Combination of Selective Inhibitor of Nuclear Export (SINE) Compounds, Selinexor and KPT-8602, with Venetoclax (ABT-199) Displays Enhanced Activity in Leukemia and Large Cell Lymphoma

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.3949.3949

Authors: Melissa A. Fischer, Sharon Friedlander, Leah Hogdal, Pia Arrate, Hua Chang, Trinayan Kashyap, Christian Argueta, Boris Klebanov, William Senapedis, Erkan Baloglu, Margaret S. Lee, Sharon Shacham, Michael R. Savona

Institutions: Vanderbilt University Medical Center, Karyopharm Therapeutics (United States), Vanderbilt University, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2713328738

FWCI: 0.966

Cites:

Cited by: 5

Related to: 10